Valuation: Virbac

Market Cap 2.72B 3.1B 2.52B 2.32B 4.38B 297B 4.47B 30.01B 11.77B 146B 11.64B 11.38B 503B P/E 2026 *
16x
P/E 2027 * 14.4x
Enterprise Value 2.84B 3.24B 2.63B 2.42B 4.58B 310B 4.67B 31.35B 12.29B 152B 12.16B 11.89B 526B EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.67x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-.--% - - 3.1B
-0.22%-0.04%-51.35%-55.91% 31.61B
+1.29%+0.04%+68.72%+137.17% 12.56B
-1.14%-7.35%-20.31%-2.50% 3.55B
-2.87%-7.14%+49.37%+22.85% 1.91B
+2.63%+3.48%-25.17%+17.39% 1.71B
+2.90%-3.31%+7.14%+124.34% 1.34B
+1.41%-1.25%-19.68%-13.81% 1.06B
+2.54%+1.68%-6.67%-18.39% 965M
+0.49%-3.32%-18.73%-48.35% 922M
Average +0.49%-0.79%-1.85%+18.09% 6.18B
Weighted average by Cap. +0.10%-0.36%-14.67%+1.96%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.43B 1.32B 2.5B 169B 2.54B 17.09B 6.7B 82.96B 6.63B 6.48B 287B 1.64B 1.88B 1.52B 1.4B 2.65B 179B 2.7B 18.16B 7.12B 88.14B 7.04B 6.89B 304B
Net income 169M 192M 156M 144M 272M 18.39B 277M 1.86B 730M 9.03B 722M 706M 31.19B 190M 216M 176M 162M 306M 20.68B 311M 2.09B 821M 10.16B 811M 794M 35.08B
Net Debt 121M 138M 112M 103M 195M 13.2B 199M 1.34B 524M 6.48B 518M 507M 22.39B 26.49M 30.2M 24.54M 22.58M 42.7M 2.89B 43.53M 292M 115M 1.42B 113M 111M 4.9B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA